Obesity and type 2 diabetes mellitus (T2DM) are among the most pressing global public health challenges of the 21st century [1,2,3], and are characterized by profound disturbances in systemic lipid metabolism and insulin action. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.